BCL2 and cancer: Interestingly, co-culturing CEVs with T cells resulted in elevated expression of BAX (proapoptotic marker) and decline in expression of BCL-2/BCL-XL (anti-apoptotic markers) indicating cancer mediated T cell suppression (Figure 5A).